Integrated Quantitative Investments’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Integrated Quantitative Investments's NVS Position: Q3 2026 in Review
Integrated Quantitative Investments increased its Novartis (NVS) stake by 0.3% in Q3 2026, buying an estimated $5.46K and bringing the position to 12,011 shares worth $1.71M. The position accounts for 0.3% of the portfolio, ranked #100.
Integrated Quantitative Investments first reported a position in NVS in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.88M in Q2 2026. 1,554 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Integrated Quantitative Investments held 12,011 shares of Novartis worth $1.71M as of Q3 2026.
- Integrated Quantitative Investments bought 36 Novartis shares in Q3 2026, an estimated $5.46K.
- Novartis made up 0.3% of Integrated Quantitative Investments's portfolio in Q3 2026, its #100 holding.
- Integrated Quantitative Investments first reported a position in Novartis in Q2 2025 and has held it in 5 quarters since.
- Integrated Quantitative Investments's Novartis position peaked at $1.88M in Q2 2026.
- 1,554 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Integrated Quantitative Investments's 13F filing for Q3 2026, filed 13 Nov 2026.